Ambrx Biopharma Investor Relations Material
Latest events
Investor Day 2023
Ambrx Biopharma
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Ambrx Biopharma Inc
Access all reports
Ambrx Biopharma Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of antibody drug conjugates (ADCs) and other engineered therapies aimed at modulating the immune system. The company is headquartered in La Jolla, California, and its shares are listed on the Nasdaq.
Latest articles
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
AMAM
Country
πΊπΈ United States